pharmaceutical investing BeiGene Announces Closing of Its HK$7.08 billion (US$903 million) Hong Kong Initial Public Offering and Global Offering
US Capital Global Facilitates $50MM Financing to Accelerate Charbone Hydrogen's North American Expansion
